- Pfizer and Moderna are both seeking emergency use authorization for their bivalent COVID boosters for children. Moderna is seeking authorization for children ages 6 through 17, while Pfizer’s shot is for children aged 5 through 11
- The U.S. Centers for Disease Control and Prevention expects the bivalent boosters will be available for children aged 5 to 11 by mid-October 2022
- In the U.S., both bivalent boosters will contain mRNA against the original Wuhan strain and Omicron variants BA.4 and BA.5. (In the U.K., Moderna’s booster targets the Wuhan strain and BA.1, an earlier Omicron strain no longer in circulation)
- The effectiveness of Pfizer’s booster is based on antibody levels in eight mice, which cannot tell you anything about the level of protection you might receive. Moderna’s booster is also based on antibody levels in mice, although the exact number is unknown
- When it comes to safety, there’s not even mouse data. The safety is assumed based on the original shots, even though the safety data on those is shocking beyond belief. As of September 16, 2022, the U.S. Vaccine Adverse Events Reporting System (VAERS) had logged 55,733 reports of injuries and deaths in children under the age of 18
Even as more damning data are coming to light, Pfizer and Moderna are both seeking emergency use authorization (EUA) for their bivalent COVID boosters for children. Moderna is seeking authorization for children ages 6 through 17, while Pfizer’s shot is for children aged 5 through 11.
According to Reuters, “the U.S. Centers for Disease Control and Prevention … expects COVID-19 vaccine boosters targeting circulating variants of the virus to be available for children aged 5-11 years by mid-October.”
Moderna’s new bivalent COVID booster, mRNA-1273.222, sold under the brand name “Spikevax bivalent Original/Omicron,” was authorized for adults over the age of 18 at the end of August 2022.
In the U.S., the adult dose contains 25 micrograms of mRNA against the original Wuhan strain and 25 mcg of mRNA targeting Omicron variants BA.4 and BA.5. In the U.K., Moderna’s bivalent booster (mRNA-1273.214) contains mRNA against the original Wuhan strain and BA.1, an earlier Omicron strain that is no longer in circulation.
Pfizer’s bivalent booster also contain mRNA against the Wuhan strain, BA.4 and BA.5. The two bivalent boosters are only be available to those who have already received the primary two-dose series and/or a monovalent booster at least two months ago.
It’s probably safe to assume the same rule will apply to children. As of late September 2022, 38% of American children aged 5 to 11 had received one initial dose and 31% have received two doses. In the 12- to 17-year-old age group, 67% have had one dose and 57% two doses. Those with two doses are likely the only ones who will be eligible for the bivalent booster, if authorized.
Bivalent Boosters Have Only Been Tested on Mice
It’s really important to realize that these bivalent boosters have been reformulated with new, untested mRNA, yet they’ve only been tested on mice. Despite that, the FDA is now considering giving them to young children.
The effectiveness of Pfizer’s booster is based on antibody levels in eight mice,13 which cannot tell you anything about the level of protection you might receive. Moderna’s booster is also based on antibody levels in mice, although the exact number is unknown.
When it comes to safety, there’s not even mouse data. The safety is assumed based on the original shots, even though the safety data on those is shocking beyond belief. In the short-term, the original COVID shots have between them resulted in 1,417,671 adverse event reports (logged with the U.S. Vaccine Adverse Events Reporting System or VAERS as of September 16, 202214).
That includes 177,973 hospitalizations, 58,024 permanent disabilities, 34,107 life threatening events and 31,071 deaths. For children under the age of 18 alone, there are 55,733 reports of injuries and deaths.
If that’s not cause for alarm, I don’t know what is. It’s certainly not “strong evidence” for safety! What’s more, due to widespread underreporting, you have to multiply those already staggering numbers by underreporting factor of 41 (or more) to get an idea of the true impact.
And, if you still believe the pediatric trials were exhaustive, understand that the monovalent Pfizer booster authorized for children aged 5 to 11, back in May 2022, was based on the antibody levels of just 67 children.15 This is so far outside the norm of what’s historically been required for a drug trial, it’s just ridiculous.
1 in 800 Absolute Risk of Serious Side Effects
While VAERS data paint a clear picture of what’s at stake for parents who opt to inject their children with this genetically engineered bioweapon, we now also have other data showing just how bad of an idea that is.
A recent study16 17 in the journal Vaccine — coauthored by some of the most trusted medical scientists in the world, including Peter Doshi, an associate professor of pharmaceutical services research and a senior editor at The BMJ — looked at data from the FDA, Health Canada and the Pfizer and Moderna trials to assess the risks of Pfizer’s and Moderna’s COVID shots.
They concluded the absolute risk of a serious adverse event from the mRNA shots was 1 in 800, which massively exceeds the risk of COVID-19 hospitalization found in randomized controlled trials.
The risk COVID infection poses to children is even more infinitesimal — especially Omicron infection, which presents as a mild cold in most people — making a 1 in 800 risk of a serious side effect unacceptable beyond description.
Statistics show the rate of COVID-19 associated hospitalization among children aged 5 to 11 is 0.0008%.18 In real-world terms, that’s so close to zero you cannot lower it any further. Additionally, as reported by Clark County Today,19 “Pfizer trial data20 [show] the chance of death in children from the shot is 107 times higher than death from COVID-19.”
Other Data That Confirm Lack of Safety
Other data are also reviewed in a recent paper21 22 by cardiologist Dr. Aseem Malhotra, who initially recommended the shots but has since changed his mind about their safety. For example, Israeli data show post-jab myocarditis is occurring at a rate of 1 in 6,000. Data from male children and teens in Hong Kong found myocarditis at a rate of 1 in 2,700.
As noted by the Vaccine Safety Research Foundation in the video above, myocarditis — one of the recognized effects of the COVID jab — “has a mortality rate of 25% to 56% within three to 10 years, owing to progressive heart failure and sudden cardiac death.”
Norwegian data show the rate of serious adverse events post-jab is 1 in 1,000 after two doses of Pfizer, and the British Yellow Card system shows 1 in 120 people who have received at least one mRNA injection suffer an adverse event “that is beyond mild.” These are simply extraordinary risk ratios, and there’s no telling what the long-term effects might be, say 10 or 20 years from now.
Trial Showed COVID Jab Increases Infection Risk in Babies
POSTED BY: DR. JOSEPH MERCOLA
Join: 👉 https://t.me/acnewspatriots
The opinions expressed by contributors and/or content partners are their own and do not necessarily reflect the views of AC.NEWS
Disclaimer: This article may contain statements that reflect the opinion of the author. The contents of this article are of sole responsibility of the author(s). AC.News will not be responsible for any inaccurate or incorrect statement in this article www.ac.news websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner. Reprinting this article: Non-commercial use OK. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.
Discussion about this post